Acta Clinica Belgica · 1999 · 10 citations · 9 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial PharmacotherapyMedical MicrobiologyMicrobial PathogenesisAntifungal PharmacotherapyAntifungal TherapyFungal InfectionsFungal PathogenesisMedical MycologyParasitic InfectionsClinical Mycological DiagnosisFungal Infections In Immunocompromised HostsGranulocyte Colony-stimulating Factor AdministrationInvasive Fungal InfectionsMucormycosis PharmacotherapyMucormycosis TreatmentOpportunistic Fungal InfectionsSevere Anemia
Mucormycosis is a rare and invasive mycotic opportunistic infection, occurring mostly in predisposed patients, mainly diabetics and immunocompromised individuals. The evolution of this fungal infection is frequently fatal unless aggressive treatment is started, or predisposing factors are handled. Our first patient was a known diabetic who had ketoacidotic coma at admission, complicated with pulmonary mucormycosis, and needed surgical resection followed by antimycotic therapy. The second patient did not survive his severe aplastic anemia (with neutropenia) and hemochromatosis (treated with desferrioxamine), complicated with a systemic Rhizopus infection, despite treatment with amphotericin B and granulocyte-colony-stimulating factors.
9
Rhinocerebral mucormycosis: Use of liposomal amphotericin B
Edward Fisher, Abbad Toma, Phillip H. Fisher et al. · The Journal of Laryngology & Otology · 1991 · 103 citations
Iron Overload Is a Risk Factor for Zygomycosis
Alan A. McNab · Archives of Ophthalmology · 1997 · 67 citations
Medicine, Hematology, Pathology +14
P. Raj, E J Vella, R C Bickerton · The Journal of Laryngology & Otology · 1998 · 54 citations